PMC:7200337 / 13457-13702 JSONTXT

{"project":"2_test","denotations":[{"id":"32505227-32192578-46575253","span":{"begin":239,"end":243},"obj":"32192578"},{"id":"T89425","span":{"begin":239,"end":243},"obj":"32192578"}],"text":"A growing body of evidence points to dysregulated myeloid responses that potentially drive the COVID-19 hallmark syndromes, such as acute respiratory distress syndrome (ARDS), cytokine release syndrome (CRS) and lymphopenia (Mehta et al., 2020)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T68174","span":{"begin":10,"end":14},"obj":"Body_part"},{"id":"T61380","span":{"begin":176,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A89488","pred":"fma_id","subj":"T68174","obj":"http://purl.org/sig/ont/fma/fma256135"},{"id":"A3845","pred":"fma_id","subj":"T61380","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"A growing body of evidence points to dysregulated myeloid responses that potentially drive the COVID-19 hallmark syndromes, such as acute respiratory distress syndrome (ARDS), cytokine release syndrome (CRS) and lymphopenia (Mehta et al., 2020)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T86","span":{"begin":95,"end":103},"obj":"Disease"},{"id":"T87","span":{"begin":132,"end":167},"obj":"Disease"},{"id":"T88","span":{"begin":138,"end":167},"obj":"Disease"},{"id":"T89","span":{"begin":169,"end":173},"obj":"Disease"},{"id":"T90","span":{"begin":203,"end":206},"obj":"Disease"},{"id":"T92","span":{"begin":212,"end":223},"obj":"Disease"}],"attributes":[{"id":"A86","pred":"mondo_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A87","pred":"mondo_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A88","pred":"mondo_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A89","pred":"mondo_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A90","pred":"mondo_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/MONDO_0007399"},{"id":"A91","pred":"mondo_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/MONDO_0017361"},{"id":"A92","pred":"mondo_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"}],"text":"A growing body of evidence points to dysregulated myeloid responses that potentially drive the COVID-19 hallmark syndromes, such as acute respiratory distress syndrome (ARDS), cytokine release syndrome (CRS) and lymphopenia (Mehta et al., 2020)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T96137","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"A growing body of evidence points to dysregulated myeloid responses that potentially drive the COVID-19 hallmark syndromes, such as acute respiratory distress syndrome (ARDS), cytokine release syndrome (CRS) and lymphopenia (Mehta et al., 2020)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":138,"end":158},"obj":"Phenotype"},{"id":"T11","span":{"begin":176,"end":201},"obj":"Phenotype"},{"id":"T12","span":{"begin":212,"end":223},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0001888"}],"text":"A growing body of evidence points to dysregulated myeloid responses that potentially drive the COVID-19 hallmark syndromes, such as acute respiratory distress syndrome (ARDS), cytokine release syndrome (CRS) and lymphopenia (Mehta et al., 2020)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"443","span":{"begin":34,"end":36},"obj":"Gene"},{"id":"445","span":{"begin":37,"end":57},"obj":"Disease"},{"id":"446","span":{"begin":95,"end":122},"obj":"Disease"},{"id":"447","span":{"begin":132,"end":167},"obj":"Disease"},{"id":"448","span":{"begin":169,"end":173},"obj":"Disease"},{"id":"449","span":{"begin":212,"end":223},"obj":"Disease"}],"attributes":[{"id":"A443","pred":"tao:has_database_id","subj":"443","obj":"Gene:6999"},{"id":"A445","pred":"tao:has_database_id","subj":"445","obj":"MESH:D021081"},{"id":"A446","pred":"tao:has_database_id","subj":"446","obj":"MESH:C000657245"},{"id":"A447","pred":"tao:has_database_id","subj":"447","obj":"MESH:D012128"},{"id":"A448","pred":"tao:has_database_id","subj":"448","obj":"MESH:D012128"},{"id":"A449","pred":"tao:has_database_id","subj":"449","obj":"MESH:D008231"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A growing body of evidence points to dysregulated myeloid responses that potentially drive the COVID-19 hallmark syndromes, such as acute respiratory distress syndrome (ARDS), cytokine release syndrome (CRS) and lymphopenia (Mehta et al., 2020)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T79","span":{"begin":0,"end":245},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A growing body of evidence points to dysregulated myeloid responses that potentially drive the COVID-19 hallmark syndromes, such as acute respiratory distress syndrome (ARDS), cytokine release syndrome (CRS) and lymphopenia (Mehta et al., 2020)."}